Ascendis Reports Five-Year Kidney Function Gains With TransCon PTH
Pooled Phase 2/3 data showed early, sustained eGFR improvements and lower urine calcium in adults with hypoparathyroidism treated with TransCon PTH for up to five years.
Pooled Phase 2/3 data showed early, sustained eGFR improvements and lower urine calcium in adults with hypoparathyroidism treated with TransCon PTH for up to five years.